Product Information
DEXAMETHASONE 0.1% EYE DROP is a generic product labeled by Bausch & Lomb Incorporated, priced at $8.1745 per ML under NDC 24208072002. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jul 26, 1996.
The High Outlier badge above means this manufacturer's average price in the Dexamethasone Sodium Phosphate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208072002
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
DEXAMETHASONE SODIUM PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA040069FDA Approved
7/26/1996
On Market Since
7/26/1996
Pharmacological Classes
Price Statistics
The NADAC for DEXAMETHASONE 0.1% EYE DROP has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 171.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.1745 per ML |
|---|---|
| All-time high | $11.1173 (May 11, 2016) |
| All-time low | $2.9335 (Aug 19, 2015) |
| 52-week high | $8.5514 |
| 52-week low | $7.4944 |
| Median price | $8.5528 |
| Average price | $7.8178 |
| Largest weekly change | +202.9% (Sep 23, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dexamethasone Sodium Phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Incorporated manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexamethasone Sodium Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXAMETHASONE 0.1% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for DEXAMETHASONE 0.1% EYE DROP, manufactured by Bausch & Lomb Incorporated, is $8.1745 per ML (NDC 24208072002), effective Sep 30, 2026.
How has the price of DEXAMETHASONE 0.1% EYE DROP changed over time?
Over the history we have for it, the NADAC for DEXAMETHASONE 0.1% EYE DROP has risen 171.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DEXAMETHASONE 0.1% EYE DROP?
Since Nov 28, 2013, the NADAC for DEXAMETHASONE 0.1% EYE DROP has ranged from a low of $2.9335 (Aug 19, 2015) to a high of $11.1173 (May 11, 2016), with a median of $8.5528 per ML.
Are there cheaper alternatives to DEXAMETHASONE 0.1% EYE DROP?
No other NADAC-published product currently shares the active ingredient and strength of DEXAMETHASONE 0.1% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXAMETHASONE 0.1% EYE DROP?
DEXAMETHASONE 0.1% EYE DROP (NDC 24208072002) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.